tirzepatide and afib GLP-1 receptor agonists, including semaglutide (Wegovy/Ozempic) (Mounjaro/Zepbound), are being recognized for benefits beyond blood sugar control and weight management. New real-world evidence suggests they may also play a role in HRS 2025: Exploring the Effects

The OAC applauds Lilly for another step forward in improving the affordability of obesity treatment, said Joe Nadglowski, president and CEO of the Obesity Action Coalition

These differences limit the ability to make assumptions about the consistency of clinical benefit in older T2D populations at high CV risk

1 Mater Research Institute, The University of Queensland, Brisbane, Australia, 2 Faculty of Health, Medicine and Behavioral Sciences, The University of Queensland, Brisbane, Australia, 3 Department of Medicine, The University of Melbourne, Austin health, Melbourne, Australia

Revisiting intensive blood glucose control: a causal directed acyclic graph-guided systematic review of randomized controlled trials

They can help you make the best choices for your health during this time

He is also a pioneer member of the new medical organization , the Clinical Peptide Society